C van Walraven1, J L Mahon, D Moher
1Department of Medicine, University of Ottawa and Clinical Epidemiology Unit, Ottawa Hospital - Civic Campus, Canada.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Determining the minimal important difference (MID) for clinical trials is complex. Physician surveys reveal that MID values vary significantly, impacting sample size calculations for treatments like propranolol for abdominal aortic aneurysms.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: